Fluticasone Propionate/Salmeterol MDPI (AirDuo RespiClick®): A Review in Asthma
J Paik, LJ Scott, RA Pleasants - Clinical Drug Investigation, 2018 - Springer
The novel, easy-to-use, breath-actuated fluticasone propionate/salmeterol multidose dry
powder inhaler (MDPI)(AirDuo RespiClick®) was recently approved in the USA for twice …
powder inhaler (MDPI)(AirDuo RespiClick®) was recently approved in the USA for twice …
Randomized, double-blind trial evaluating the efficacy and safety of fluticasone propionate and fluticasone propionate/salmeterol delivered via multidose dry powder …
G Raphael, G Yiu, A Sakov, S Liu, C Caracta - Journal of Asthma, 2018 - Taylor & Francis
Objective: To assess the efficacy and safety of fluticasone propionate (Fp) and Fp/salmeterol
(FS) administered via a novel multidose dry powder inhaler (MDPI) that is easy to use …
(FS) administered via a novel multidose dry powder inhaler (MDPI) that is easy to use …
Fluticasone propionate and fluticasone propionate/salmeterol multidose dry powder inhalers compared with placebo for persistent asthma
LD Sher, G Yiu, A Sakov, S Liu… - Allergy and Asthma …, 2017 - ingentaconnect.com
Background: A novel, inhalation-driven, multidose dry powder inhaler (MDPI) has been
developed, which allows for lower doses of fluticasone propionate (Fp) and Fp/salmeterol …
developed, which allows for lower doses of fluticasone propionate (Fp) and Fp/salmeterol …
Safety, efficacy, and dose response of fluticasone propionate delivered via the novel MDPI in patients with severe asthma: a randomized, controlled, dose-ranging …
DI Bernstein, M Gillespie, S Song, J Steinfeld - Journal of Asthma, 2017 - Taylor & Francis
ABSTRACT Objective: Evaluate fluticasone propionate (Fp) using a novel, inhalation-driven,
multidose dry powder inhaler (MDPI) in patients with severe persistent asthma, versus …
multidose dry powder inhaler (MDPI) in patients with severe persistent asthma, versus …
[HTML][HTML] A 6-month safety and efficacy study of fluticasone propionate and fluticasone propionate/salmeterol multidose dry powder inhalers in persistent asthma
L Mansfield, G Yiu, A Sakov, S Liu… - Allergy and Asthma …, 2017 - ingentaconnect.com
Background: A novel multidose dry powder inhaler (MDPI) that is breath actuated, easy, and
intuitive to use has been developed for administering fluticasone propionate (Fp) and …
intuitive to use has been developed for administering fluticasone propionate (Fp) and …
Dose-ranging study to evaluate the efficacy and safety of four doses of fluticasone propionate/salmeterol multidose dry powder inhaler (FS MDPI) compared with …
J Steinfeld, G Yiu, SD Miller - Journal of Allergy and Clinical …, 2015 - jacionline.org
Methods Multicenter, randomized, double-blind, single-dose, 6-period crossover, dose-
ranging study in subjects aged≥ 12 years with persistent asthma and predose maximum …
ranging study in subjects aged≥ 12 years with persistent asthma and predose maximum …
[PDF][PDF] Randomized equivalence trial: A novel multidose dry powder inhaler and originator device in adult and adolescent asthma
P Kuna, U Thyroff-Friesinger, I Gath… - Allergy Asthma Proc, 2015 - researchgate.net
Background: Guideline-defined asthma control can be achieved and maintained in patients
by treatment with fluticasone propionate–salmeterol (FP-Sal). Objective: To compare the …
by treatment with fluticasone propionate–salmeterol (FP-Sal). Objective: To compare the …
The pharmacokinetics, safety, and tolerability of single, high-strength doses of fluticasone propionate and fluticasone propionate/salmeterol delivered via a novel …
C Nugent, G Yiu, S Song, C Caracta - Journal of Asthma, 2018 - Taylor & Francis
ABSTRACT Objective: Characterize fluticasone propionate (Fp) and combination fluticasone
propionate and salmeterol (FS) pharmacokinetic and safety profiles, delivered via a novel …
propionate and salmeterol (FS) pharmacokinetic and safety profiles, delivered via a novel …
A dose-ranging study of fluticasone propionate administered once daily via multidose powder inhaler to patients with moderate asthma
RA Nathan, JTC Li, A Finn, R Jones, JE Payne… - Chest, 2000 - Elsevier
Study objective This dose-ranging study evaluated the clinical efficacy and safety of inhaled
fluticasone propionate administered once daily via a multidose powder inhaler in patients …
fluticasone propionate administered once daily via a multidose powder inhaler in patients …
Long-term efficacy and safety of fluticasone propionate powder administered once or twice daily via inhaler to patients with moderate asthma
R ZuWallack, J Adelglass, DP Clifford, SP Duke… - Chest, 2000 - Elsevier
Objective To evaluate the efficacy and safety of fluticasone propionate administered as a
once-daily or twice-daily regimen over a period of 1 year to patients with moderate asthma …
once-daily or twice-daily regimen over a period of 1 year to patients with moderate asthma …